Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV ClassificationCharlotte Hedskog, Evguenia S. Svarovskaia, Bandita Parhy et al.|Open Forum Infectious Diseases|2019Cited by 119
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia‐Horng Kao, Wan‐Long Chuang, Rong‐Nan Chien et al.|Liver International|2016Cited by 29
Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan‐Long Chuang, Jia‐Horng Kao, Rong‐Nan Chien et al.|Journal of Gastroenterology and Hepatology|2016Cited by 27
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Zhongping Duan, Qing Xie et al.|Hepatology International|2018Cited by 22
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypesNimisha Chaturvedi, Jacques Fellay, Evguenia S. Svarovskaia et al.|eLife|2019Cited by 19